Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Early Stage Non-Small Cell Lung Cancer 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Bevacizumab 47 lenvatinib 36 atezolizumab 36 durvalumab 28 tremelimumab 23 sintilimab 19 Nivolumab 18 pembrolizumab 14 Radiosurgery 13 tislelizumab 11 Specimen Handling 10 Ipilimumab 10 camrelizumab 8 apatinib 8 Oxaliplatin 8 Immune Checkpoint Inhibitors 8 Fluorouracil 8 Cyclophosphamide 8 Blood Specimen Collection 8 regorafenib 7 cabozantinib 7 fludarabine 6 Sorafenib 6 Radiotherapy 6 Magnetic Resonance Spectroscopy 6 Leucovorin 6 donafenib 5 Surgical Procedures, Operative 5 Injections 5 Immunoglobulin G 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Hepatocellular × Vancomycin × Clear all

NCT05690048 2025-08-06

FLORA

University Hospital Heidelberg

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡